Table 2.
a: Controls Baseline vs. Post-furosemide R2* | ||||
---|---|---|---|---|
Region | Baseline R2* (s−1) | Post R2* (s−1) | P-value † | d ‡ |
Large Cortex | 19.6 ± 3.6 | 18.7 ± 4.7 | 0.22 | 0.21 |
Medulla | 30.9 ± 4.1 | 22.5 ± 5.0 | 0.002 | 1.59 |
Parenchyma | 23.8 ± 2.7 | 20.6 ± 4.1 | 0.002 | 0.84 |
b: CKD Baseline vs. Post-furosemide R2* | ||||
---|---|---|---|---|
Region | Baseline R2* (s−1) | Post R2* (s−1) | P-value † | d ‡ |
Large Cortex | 23.9 ± 7.3 | 22.0 ± 6.9 | 0.056 | 0.22 |
Medulla | 29.7 ± 7.2 | 26.7 ± 7.0 | 0.039 | 0.35 |
Parenchyma | 26.3 ± 6.1 | 24.8 ± 5.6 | 0.004 | 0.21 |
Wilcoxon signed rank test statistic
Cohen’s d measure of effect size